Aurora Spine Corporation

TSXV:ASG 株式レポート

時価総額:CA$34.8m

Aurora Spine 将来の成長

Future 基準チェック /06

現在、 Aurora Spineの成長と収益を予測するのに十分なアナリストの調査がありません。

主要情報

n/a

収益成長率

n/a

EPS成長率

Medical Equipment 収益成長17.1%
収益成長率n/a
将来の株主資本利益率n/a
アナリストカバレッジ

None

最終更新日n/a

今後の成長に関する最新情報

Recent updates

Aurora Spine Corporation (CVE:ASG) Soars 26% But It's A Story Of Risk Vs Reward

Oct 19
Aurora Spine Corporation (CVE:ASG) Soars 26% But It's A Story Of Risk Vs Reward

We Think Aurora Spine (CVE:ASG) Has A Fair Chunk Of Debt

Oct 16
We Think Aurora Spine (CVE:ASG) Has A Fair Chunk Of Debt

Aurora Spine Corporation's (CVE:ASG) Subdued P/S Might Signal An Opportunity

Aug 14
Aurora Spine Corporation's (CVE:ASG) Subdued P/S Might Signal An Opportunity

We Think Shareholders May Want To Consider A Review Of Aurora Spine Corporation's (CVE:ASG) CEO Compensation Package

Jun 19
We Think Shareholders May Want To Consider A Review Of Aurora Spine Corporation's (CVE:ASG) CEO Compensation Package

Is Aurora Spine (CVE:ASG) A Risky Investment?

May 29
Is Aurora Spine (CVE:ASG) A Risky Investment?

There Is A Reason Aurora Spine Corporation's (CVE:ASG) Price Is Undemanding

Mar 19
There Is A Reason Aurora Spine Corporation's (CVE:ASG) Price Is Undemanding

Would Aurora Spine (CVE:ASG) Be Better Off With Less Debt?

Oct 15
Would Aurora Spine (CVE:ASG) Be Better Off With Less Debt?

Why Investors Shouldn't Be Surprised By Aurora Spine Corporation's (CVE:ASG) Low P/S

Aug 11
Why Investors Shouldn't Be Surprised By Aurora Spine Corporation's (CVE:ASG) Low P/S

Here's Why Aurora Spine (CVE:ASG) Can Afford Some Debt

May 01
Here's Why Aurora Spine (CVE:ASG) Can Afford Some Debt

Aurora Spine (CVE:ASG) Is Making Moderate Use Of Debt

Dec 22
Aurora Spine (CVE:ASG) Is Making Moderate Use Of Debt

Would Aurora Spine (CVE:ASG) Be Better Off With Less Debt?

Aug 23
Would Aurora Spine (CVE:ASG) Be Better Off With Less Debt?

Health Check: How Prudently Does Aurora Spine (CVE:ASG) Use Debt?

May 04
Health Check: How Prudently Does Aurora Spine (CVE:ASG) Use Debt?

Health Check: How Prudently Does Aurora Spine (CVE:ASG) Use Debt?

Dec 23
Health Check: How Prudently Does Aurora Spine (CVE:ASG) Use Debt?

Aurora Spine (CVE:ASG) Is Making Moderate Use Of Debt

Jun 11
Aurora Spine (CVE:ASG) Is Making Moderate Use Of Debt

A Look At The Intrinsic Value Of Aurora Spine Corporation (CVE:ASG)

Feb 26
A Look At The Intrinsic Value Of Aurora Spine Corporation (CVE:ASG)

Is Aurora Spine (CVE:ASG) A Risky Investment?

Nov 19
Is Aurora Spine (CVE:ASG) A Risky Investment?

このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Aurora Spine は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。

シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。

業績と収益の成長予測

TSXV:ASG - アナリストの将来予測と過去の財務データ ( )USD Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
9/30/202417-1-10N/A
6/30/202416-1-10N/A
3/31/202416-1-10N/A
12/31/202315-2-1-1N/A
9/30/202314-2-10N/A
6/30/202314-2-10N/A
3/31/202314-2-1-1N/A
12/31/202215-2-2-2N/A
9/30/202214-2-3-1N/A
6/30/202213-2-4-3N/A
3/31/202212-2-4-3N/A
12/31/202111-2-3-2N/A
9/30/202110-1-3-2N/A
6/30/20219-1-1-1N/A
3/31/20219000N/A
12/31/20209000N/A
9/30/20209-101N/A
6/30/20209-200N/A
3/31/202011-2-10N/A
12/31/201911-100N/A
9/30/201911-100N/A
6/30/201911000N/A
3/31/201910001N/A
12/31/20189000N/A
9/30/20188-100N/A
6/30/20187-1N/A-1N/A
3/31/20186-2N/A-1N/A
12/31/20176-2N/A-1N/A
9/30/20176-2N/A-1N/A
6/30/20176-2N/A-1N/A
3/31/20177-2N/A-2N/A
12/31/20167-2N/A-2N/A
9/30/20167-2N/A-2N/A
6/30/20166-2N/A-2N/A
3/31/20165-2N/A-2N/A
12/31/20155-3N/A-3N/A
9/30/20155-5N/A-4N/A
6/30/20154-6N/A-6N/A
3/31/20154-8N/A-7N/A
12/31/20143-8N/A-7N/A
9/30/20141-6N/A-7N/A
6/30/20141-5N/A-5N/A
3/31/20140-4N/A-4N/A
12/31/20130-3N/A-3N/A

アナリストによる今後の成長予測

収入対貯蓄率: ASGの予測収益成長が 貯蓄率 ( 2.3% ) を上回っているかどうかを判断するにはデータが不十分です。

収益対市場: ASGの収益がCanadian市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です

高成長収益: ASGの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。

収益対市場: ASGの収益がCanadian市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。

高い収益成長: ASGの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。


一株当たり利益成長率予想


将来の株主資本利益率

将来のROE: ASGの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です


成長企業の発掘